Novel Rapid-Acting Drug Proves Effective in Severe PTSD



(MedPage Today) — The investigational neuroplastogen TSND-201 showed significant efficacy in patients with severe post-traumatic stress disorder (PTSD), according to results from a phase II randomized trial.
Among 65 patients, treatment with…



Source link : https://www.medpagetoday.com/psychiatry/anxietystress/119935

Author :

Publish date : 2026-02-18 20:52:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version